In a 3‑year‑old child who vomits after receiving an intramuscular injection of undiluted 1:1000 epinephrine (adrenaline) 0.2 mL in the anterolateral thigh for urticaria, what is the likely cause and how should it be treated?

Vomiting After IM Epinephrine in a 3-Year-Old: Cause and Treatment

The vomiting is most likely a recognized gastrointestinal manifestation of either the ongoing anaphylaxis itself or a pharmacologic effect of epinephrine, and should be managed by positioning the child appropriately (on their back or sitting upright if respiratory distress present, with legs elevated), continuing to monitor for progression of anaphylaxis, and being prepared to administer a second dose of epinephrine if symptoms worsen or persist. 1

Understanding the Clinical Context

The Dose Was Appropriate

For a 3-year-old child receiving 0.2 mL of 1:1000 epinephrine IM (0.2 mg), this dose falls within guideline recommendations. The FDA-approved dosing is 0.01 mg/kg up to 0.3 mg maximum for children under 30 kg 2. The anterolateral thigh route was correct 1, 2.

Why Vomiting Occurred: Two Possibilities

1. Vomiting as Part of Anaphylaxis

• Gastrointestinal symptoms including nausea, crampy abdominal pain, and persistent vomiting are recognized manifestations of anaphylaxis itself 1, 3
• The child presented with urticaria, which could represent early anaphylaxis that is now progressing to involve the GI system
• This is particularly concerning because it suggests the reaction may be evolving

2. Vomiting as a Pharmacologic Effect of Epinephrine

• Nausea and vomiting are listed as common adverse reactions to systemically administered epinephrine 2
• These are pharmacologic effects that occur even at therapeutic doses

Critical Management Steps

Immediate Actions

Position the patient correctly:

• Place the child on their back with legs elevated
• If there is respiratory distress and/or continued vomiting, allow the child to sit upright with legs extended and elevated
• Never allow the child to stand, walk, or run 1

Monitor closely for progression:

• Assess airway, breathing, circulation continuously
• Watch for additional anaphylaxis symptoms: respiratory compromise (wheeze, stridor, difficulty breathing), cardiovascular symptoms (hypotension, tachycardia, collapse), or worsening skin/GI symptoms 1, 3

Be prepared to give a second epinephrine dose:

• If symptoms persist or worsen, administer a second IM injection of 0.2 mg (0.2 mL) in the opposite anterolateral thigh
• This can be repeated every 5-15 minutes as necessary 1, 2
• Approximately 6-19% of pediatric patients require a second dose 1

Transport and Further Care

Call for emergency medical services (911) or transport to emergency department:

• Even if symptoms improve, the child requires observation in a medical facility
• Additional treatment may include supplemental oxygen, IV fluids, and other interventions 1
• Biphasic reactions can occur hours later

Important Clinical Pitfalls

Do not assume the vomiting means the epinephrine was wrong or harmful:

• There is no absolute contraindication to epinephrine in anaphylaxis 2
• The benefits of epinephrine far outweigh the risks of transient side effects
• Serious adverse effects from IM epinephrine are rare in children 1

Do not rely on antihistamines alone:

• If this represents evolving anaphylaxis, antihistamines are insufficient
• Epinephrine is the only first-line, life-saving medication 1, 4

Do not delay a second dose if clinically indicated:

• The presence of vomiting (whether from anaphylaxis progression or epinephrine effect) should not deter appropriate repeat dosing if the child shows signs of persistent or worsening anaphylaxis
• Clinical judgment is paramount—when uncertain, err on the side of administering epinephrine 1, 3

Distinguish between isolated urticaria and anaphylaxis:

• Isolated allergen-associated urticaria may respond to antihistamines alone 3
• However, if urticaria occurs with known allergen exposure in a child with prior anaphylaxis history, or if GI symptoms develop, this suggests anaphylaxis requiring epinephrine 1, 3

Key Takeaway

The vomiting does not indicate a medication error or overdose (the dose and route were correct). It represents either disease progression or an expected pharmacologic effect. The priority is continued monitoring and readiness to treat evolving anaphylaxis with repeat epinephrine while ensuring proper patient positioning and arranging emergency transport.